46. Provisions Accounting Policies
A provision is recognized if, as a result of a past event, the Company has a present legal or constructive obligation that can be estimated reliably, and it is probable that an outflow of economic benefits will be required to settle the obligation. If the effect of the time value of money is material, provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and the risks specific to the liability. Where discounting is used, the increase in the provision due to the passage of time is recognized as a finance cost.
The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the reporting date, considering the risks and uncertainties surrounding the obligation. When some or all the economic benefits required to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received, and the amount of the receivable can be measured reliably.
A contract is considered to be onerous when the expected economic benefits to be derived by the Company from the contract are lower than the unavoidable cost of meeting its obligations under the contract. The provision for an onerous contract is measured at the present value of the lower of the expected cost of terminating the contract and the expected net cost of continuing with the contract. Before such a provision is made, the Company recognizes any impairment loss on the assets associated with that contract.
Provisions are reviewed at each balance sheet date and adjusted to reflect the current best estimate. If it is no longer probable that the outflow of resources would be required to settle the obligation, the provision is reversed.
47. Segment Reporting
i) Primary Segment (Business Segment)
The Company operates only in the business segment of “Pharmaceuticals Products”, and in the opinion of the management the inherent nature of activities in which it is engaged are governed by the same set of risks and rewards. As such the activities are identified as single segment in accordance with the Indian Accounting Standard (Ind AS 108) issued under Companies (Indian Accounting Standards) Rules, 2016 as amended up to date.
In view of the interwoven/intermix nature of business and manufacturing facility, other segmental information is not ascertainable.
iii) Revenue from Major Customers
Revenue from one customer of the company pharmaceutical segment represented approximately ' 1,262.72 million (Previous year ' 2,274.08 million) of the company’s total revenue.
48. Other Borrowing Costs
Other Borrowing Costs include gain on account of foreign exchange fluctuation (net) amounting to ' 85.27 million (Previous Year ' 97.50 million).
Accounting Policies
Borrowing costs that are attributable to the acquisition or construction of qualifying assets are capitalized. Other borrowing costs are recognized as an expense in the period in which they are incurred.
49. Leases
Operating leases are mainly in the nature of lease of office premises with no restrictions and are renewable/cancellable at mutual consent. There are no restrictions imposed by lease arrangements. There are no sub leases. Lease payments recognized in the Statement of Profit and Loss Account are ' 20.31 million (Previous Year ' 18.89 million).
Accounting Policies
Basic earnings per share is calculated by dividing the net profit or loss for the period attributable to equity shareholders by the weighted average number of equity-shares outstanding during the period.
Diluted earnings per share is calculated by dividing the net profit or loss for the period attributable to equity shareholders by the weighted average number of equity-shares outstanding during the year after adjusted for the effects of all dilutive potential equity shares.
54. Related Party Disclosures
Related party disclosures as required under Indian Accounting Standard (Ind AS 24) on “Related Party Disclosures” issued under Companies (Indian Accounting Standards) Rule 2016, as amended up to date, are given below: -
a) Relationship
i) Subsidiary Companies
• Neclife PT, Unipessoal LDA - Portugal (Inoperative during the year)
ii) Key Management Personnel
• Mr. Sanjiv Goyal, Chairman & Managing Director
• Mr. Puneet Sud, Whole-time Director
• Mr. Amit Chadah, Chief Executive Officer
• Mr. Sushil Kapoor, Chief Financial Officer
• Ms. Neha, Company Secretary (upto 28.02.2025)
• Mr. Sanjaymohan Singh Rawat, Company Secretary (w.e.f. 01.04.2025)
iii) Joint Ventures and Associates
• None
# The matters are subject to legal proceedings in the ordinary course of business. In the opinion of the management, legal proceedings for cases, when ultimately concluded, will not have a material effect on the results of operation or financial position of the company.
** MAT credit entitlement would be reduced by ' 580.98 million, in case of adverse judgment and ' 299.00 million will be adjusted against the MAT credit entitlement already lapsed in the books of accounts.
@Amount deposited under protest ' 25.62 million.
# Amount deposited under protest ' 0.52 million.
# In case demand is confirmed, penalty up to equivalent amount may be imposed.
$ Amount deposited under protest “Nil” (Previous year ' 3.44 million).
Interest and claims by customers, suppliers, lenders, and employees may be payable as and when the outcome of the related matters is finally determined and hence have not been included above. Management based on legal advice and historical trends, believes that no material liability will devolve on the Company in respect of these matters.
Accounting Policies
A contingent liability is a possible obligation that arises from past events whose existence will be confirmed by the occurrence or non-occurrence of one or more uncertain future events beyond the control of the Company or a present obligation that is not recognised because it is not probable that an outflow of resources will be required to settle the obligation.
A contingent liability also arises in extremely rare cases where there is a liability that cannot be recognised because it cannot be measured reliably. The Company does not recognise a contingent liability but discloses its existence in the financial statements unless the possibility of an outflow of resources embodying economic benefits is remote. Contingent liabilities and commitments are reviewed by the management at each balance sheet date.
Contingent assets are neither recognised nor disclosed in the financial statements. However, contingent assets are assessed continually and if it is virtually certain that an inflow of economic benefits will arise, the asset and related income are recognised in the period in which the change occurs.
56. Derivatives Currency derivatives
The Company uses foreign currency forward contracts and currency options to hedge its risks associated with foreign currency fluctuations relating to certain firm commitments and forecasted transactions. The use of foreign currency forward contracts and currency options is governed by the Company’s strategy. The Company does not use forward contracts and currency options for speculative purposes.
57. Disclosure of Transactions with Struck off Companies:
As per the information available with the company, the Company did not have any material transactions with companies struck off under Section 248 of the Companies Act, 2013 or Section 560 of Companies Act, 1956 during the financial year.
58. Capital Management:
For the purpose of the Company’s capital management, capital includes issued equity capital, and all other equity reserves attributable to the equity holders of the Company. The primary objective of the Company’s capital management is to safeguard the Company’s ability to remain as a going concern and maximize the shareholder value.
The Company manages its capital structure and makes adjustments in light of changes in economic conditions, annual operating plans and long-term and other strategic investment plans. In order to maintain or adjust the capital structure, the Company may adjust the amount of dividends paid to shareholders, return capital to shareholders or issue new shares. The current capital structure of the Company is equity based with no financing through borrowings except through leasing. The Company is not subject to any externally imposed capital requirements.
No changes were made in the objectives, policies or processes for managing capital during the year ended March 31, 2025 and March 31,2024.
59. Credit Rating
The following table presents an analysis of the credit quality of debt securities issued by the Parent Company and its subsidiary. Rating has been obtained from credit rating agency CARE Ratings Ltd (Pervious year from Brickwork Ratings India Private Ltd). The details of which are as below:
60. Additional Regulatory Disclosure Requirements
No transactions to report against the following disclosure requirements as notified by MCA pursuant to amended Schedule III:
a. Crypto Currency or Virtual Currency
b. Benami Property held under Prohibition of Benami Property Transactions Act, 1988 and rules made thereunder
c. Registration of charges or satisfaction with Registrar of Companies
d. Compliance with number of layers of companies
e. Relating to borrowed funds:
i. Willful defaulter
ii. Utilization of borrowed funds & share premium
iii. Borrowings obtained on the basis of security of current assets
iv. Discrepancy in utilization of borrowings
v. Current maturity of long-term borrowings
f. Title deeds of immoveable properties not held in name of company.
g. Relationship with Struck off Companies.
h. Revaluation of property, Plant and equipment as no such revaluation taken place during the year.
Comments for variations above 25%, if any:
1. The company has incurred losses during FY 2024-25 whereas the company earned profits during FY 2023-24 leading to decline in ratio of debt service coverage ratio, Return on Equity (ROE), Net profit ratio and Return on capital employed (ROCE).
2. During FY 2024-25, sales of the company (net of GST) have declined to ' 16,699.74 million as compared to ' 16,840.86 million in FY 2023-24 and the working capital of the company have been declined to ' 2,160.44 Million in FY 2024-25 as compared to ' 3,110.14 million in FY 2023-24. Both these factors have resulted in an improvement of Net capital turnover ratio.
62. The Company has re-grouped the previous year’s figures to confirm the current year’s classification.
FOR NECTAR LIFESCIENCES LIMITED For Deepak Jindal & Co.
CHARTERED ACCOUNTANTS Firm Regn. No. 023023N
Sanjiv Goyal Amit Chadah (Onkar Singh)
Chairman & Managing Director Chief Executive Officer Partner
DIN: 00002841 M. No. 514746
Sushil Kapoor Sanjaymohan Singh Rawat
Chief Financial Officer Company Secretary
Place: Chandigarh Date: 07.07.2025
|